Switch theme
Sign up to access all valuation multiples
MatsukiyoCocokara & Co, formerly Matsumotokiyoshi Holdings Co., Ltd. is a large retail pharmacy in Japan. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, discount cosmetics, household items, pet supplies, groceries, and personal care products. Matsumotokiyoshi operates a private brand called matsukiyo. The highest concentration of Matsumotokiyoshi's stores are in the Kanto region, which includes Tokyo.
2007
14.6K+
LTM Revenue $7.1B
LTM EBITDA $667M
$6.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
MatsukiyoCocokara has a last 12-month revenue of $7.1B and a last 12-month EBITDA of $667M.
In the most recent fiscal year, MatsukiyoCocokara achieved revenue of $6.8B and an EBITDA of $689M.
MatsukiyoCocokara expects next 12-month revenue of XXX and NTM EBITDA of XXX
See MatsukiyoCocokara valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $6.3B | $6.8B | XXX | XXX | XXX |
| Gross Profit | $1.6B | $2.2B | XXX | XXX | XXX |
| Gross Margin | 25% | 32% | XXX | XXX | XXX |
| EBITDA | $570M | $689M | XXX | XXX | XXX |
| EBITDA Margin | 9% | 10% | XXX | XXX | XXX |
| Net Profit | $230M | $269M | XXX | XXX | XXX |
| Net Margin | 4% | 4% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, MatsukiyoCocokara's stock price is JPY 2531 (or $17).
MatsukiyoCocokara has current market cap of JPY 1.02T (or $6.8B), and EV of JPY 932B (or $6.2B).
See MatsukiyoCocokara trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6.2B | $6.8B | XXX | XXX | XXX | XXX | $0.87 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, MatsukiyoCocokara has market cap of $6.8B and EV of $6.2B.
MatsukiyoCocokara's trades at 0.9x LTM EV/Revenue multiple, and 9.3x LTM EBITDA.
Analysts estimate MatsukiyoCocokara's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for MatsukiyoCocokara and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $6.2B | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | 9.2x | XXX | XXX | XXX |
| P/E | 19.2x | XXX | XXX | XXX |
| P/E/Growth | 3.6x | XXX | XXX | XXX |
| EV/FCF | 22.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpMatsukiyoCocokara's NTM/LTM revenue growth is 3%
MatsukiyoCocokara's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, MatsukiyoCocokara's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate MatsukiyoCocokara's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for MatsukiyoCocokara and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 21% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 13% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.5M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 0% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 27% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| Oriola | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
MatsukiyoCocokara acquired XXX companies to date.
Last acquisition by MatsukiyoCocokara was XXXXXXXX, XXXXX XXXXX XXXXXX . MatsukiyoCocokara acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was MatsukiyoCocokara founded? | MatsukiyoCocokara was founded in 2007. |
| Where is MatsukiyoCocokara headquartered? | MatsukiyoCocokara is headquartered in Japan. |
| How many employees does MatsukiyoCocokara have? | As of today, MatsukiyoCocokara has 14.6K+ employees. |
| Is MatsukiyoCocokara publicy listed? | Yes, MatsukiyoCocokara is a public company listed on TKS. |
| What is the stock symbol of MatsukiyoCocokara? | MatsukiyoCocokara trades under 3088 ticker. |
| When did MatsukiyoCocokara go public? | MatsukiyoCocokara went public in 2007. |
| Who are competitors of MatsukiyoCocokara? | Similar companies to MatsukiyoCocokara include e.g. MedPlus India, Pague Menos, Droga Raia, Redcare Pharmacy. |
| What is the current market cap of MatsukiyoCocokara? | MatsukiyoCocokara's current market cap is $6.8B |
| What is the current revenue of MatsukiyoCocokara? | MatsukiyoCocokara's last 12-month revenue is $7.1B. |
| What is the current EBITDA of MatsukiyoCocokara? | MatsukiyoCocokara's last 12-month EBITDA is $667M. |
| What is the current EV/Revenue multiple of MatsukiyoCocokara? | Current revenue multiple of MatsukiyoCocokara is 0.9x. |
| What is the current EV/EBITDA multiple of MatsukiyoCocokara? | Current EBITDA multiple of MatsukiyoCocokara is 9.3x. |
| What is the current revenue growth of MatsukiyoCocokara? | MatsukiyoCocokara revenue growth between 2023 and 2024 was 7%. |
| Is MatsukiyoCocokara profitable? | Yes, MatsukiyoCocokara is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
